MyMD Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MYMD and buy or sell other stocks, ETFs, and their options commission-free!About MYMD
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms.
CEOChristopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees2
Employees2
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1989
Founded1989
Employees2
Employees2
MYMD Key Statistics
Market cap9.55M
Market cap9.55M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume1.82M
Average volume1.82M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.45
52 Week high$2.45
52 Week low$0.1615
52 Week low$0.1615
People also own
Based on the portfolios of people who own MYMD. This list is generated using Robinhood data, and it’s not a recommendation.